About
Omniose develops a recombinant plasminogen-based protein therapy to promote healing of chronic wounds, such as diabetic foot ulcers, by reactivating the body's natural wound healing process.
Explore Omniose's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.